Search

Your search keyword '"Choudhary, Narendra S."' showing total 28 results
Start Over Author "Choudhary, Narendra S." Publication Year Range Last 3 years Language english
28 results on '"Choudhary, Narendra S."'

1. APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure

Author

Maiwall, Rakhi, Singh, Satender Pal, Angeli, Paolo, Moreau, Richard, Krag, Aleksander, Singh, Virender, Singal, Ashwani K., Tan, S. S., Puri, Puneet, Mahtab, Mamun, Lau, George, Ning, Qin, Sharma, Manoj Kumar, Rao, P. N., Kapoor, Dharmesh, Gupta, Subhash, Duseja, Ajay, Wadhawan, Manav, Jothimani, Dinesh, Saigal, Sanjiv, Taneja, Sunil, Shukla, Akash, Puri, Pankaj, Govil, Deepak, Pandey, Gaurav, Madan, Kaushal, Eapen, C. E., Benjamin, Jaya, Chowdhury, Ashok, Singh, Shweta, Salao, Vaishali, Yang, Jin Mo, Hamid, Saeed, Shalimar, Jasuja, Sanjiv, Kulkarni, Anand V., Niriella, Madund A., Tevethia, Harsh Vardhan, Arora, Vinod, Mathur, R. P., Roy, Akash, Jindal, Ankur, Saraf, Neeraj, Verma, Nipun, De, Arka, Choudhary, Narendra S., Mehtani, Rohit, Chand, Phool, Rudra, Omkar, and Sarin, Shiv Kumar

Published
2024
Full Text
View/download PDF

2. Asia–Pacific association for study of liver guidelines on management of ascites in liver disease

Author

Singh, Virendra, De, Arka, Mehtani, Rohit, Angeli, Paolo, Maiwall, Rakhi, Satapathy, Sanjaya, Singal, Ashwini K., Saraya, Anoop, Sharma, B. C., Eapen, C. E., Rao, P. N., Shukla, Akash, Shalimar, Choudhary, Narendra S., Alcantara-Payawal, Diana, Arora, Vinod, Aithal, Guru, Kulkarni, Anand, Roy, Akash, Shrestha, Ananta, Mamun al Mahtab, Niriella, Madunil A., Siam, Tan Soek, Zhang, Chun-Qing, Huei, Lee Guan, Yu, Ming-Lung, Roberts, Stuart K., Peng, Cheng-Yuan, Chen, Tao, George, Jacob, Wong, Vincent, Yilmaz, Yusuf, Treeprasertsuk, Sombat, Kurniawan, Juferdy, Kim, Seung Up, Younossi, Zobair M., and Sarin, Shiv Kumar

Published
2023
Full Text
View/download PDF

7. Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

Author

Duseja, Ajay, Singh, S.P., De, Arka, Madan, Kaushal, Rao, Padaki Nagaraja, Shukla, Akash, Choudhuri, Gourdas, Saigal, Sanjiv, Shalimar, Arora, Anil, Anand, Anil C., Das, Ashim, Kumar, Ashish, Eapen, Chundamannil E., Devadas, Krishnadas, Shenoy, Kotacherry T., Panigrahi, Manas, Wadhawan, Manav, Rathi, Manish, Kumar, Manoj, Choudhary, Narendra S., Saraf, Neeraj, Nath, Preetam, Kar, Sanjib, Alam, Seema, Shah, Samir, Nijhawan, Sandeep, Acharya, Subrat K., Aggarwal, Vinayak, Saraswat, Vivek A., and Chawla, Yogesh K.

Published
2023
Full Text
View/download PDF

12. Minimizing Incision in Living Donor Liver Transplantation: Initial Experience and Comparative Analysis of Upper Midline Incision in 115 Recipients.

Author

Rastogi, Amit, Gupta, Ankur A., Bansal, Raghav, Valappil, Fysal Kollanta, Yadav, Kamal S., Chaudhary, Suchet, Bhangui, Prashant, Dhampalvar, Swapnil, Choudhary, Narendra S., Saraf, Neeraj, and Soin, Arvinder S.

Subjects
LIVER transplantation, COMPARATIVE studies, TREATMENT effectiveness, PLEURAL effusions, BOWEL obstructions, CHOLANGIOGRAPHY, KIDNEY transplantation
Abstract

Living donor liver transplantation (LDLT) needs "Mercedes Benz" or "J-shaped" incision, causing short and long-term complications. An upper midline incision (UMI) is less invasive alternative but technically challenging. Reporting UMI for recipients in LDLT vs. conventional J-shaped incision. Retrospective analysis, July 2021 to December 2022. Peri-operative details and post-transplant outcomes of 115 consecutive adult LDLT recipients transplanted with UMI compared with 140 recipients with J-shaped incision. Cohorts had similar preoperative and intraoperative variables. The UMI group had significant shorter time to ambulation (3 ± 1.6 vs. 3.6 ± 1.3 days, p = 0.001), ICU stay (3.8 ± 1.3 vs. 4.4 ± 1.5 days, p = 0.001), but a similar hospital stay (15.6±7.6 vs. 16.1±10.9 days, p = 0.677), lower incidence of pleural effusion (11.3% vs. 27.1% p = 0.002), and post-operative ileus (1.7% vs. 9.3% p = 0.011). The rates of graft dysfunction (4.3% vs. 8.5% p = 0.412), biliary complications (6.1% vs. 12.1% p = 0.099), 90-day mortality (7.8% vs. 12.1% p = 0.598) were similar. UMI-LDLT afforded benefits such as reduced pleuropulmonary complications, better early post-operative recovery and reduction in scar-related complaints in the medium-term. This is a safe, non-inferior and reproducible technique for LDLT. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. FRI-231 Compared to complete abstainers, non-significant alcohol use may be associated with more severe liver disease in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)-The multicentre study of the indian consortium on MASLD

Author

Duseja, Ajay Kumar, Mehta, Manu, De, Arka, Singh, Shivaram Prasad, Mukewar, Shrikant, Mukewar, Saurabh, Shalimar, Shalimar, Goyal, Omesh, Venkataraman, Jayanthi, Dixit, VK, Devadas, Krishnadas, Mehta, Varun, Ranjan, Piyush, Arora, Anil, Nagral, Abha, Choudhary, Narendra S., Kar, Sanjib, Sharma, Brij, Nijhawan, Sandeep, Praharaj, Dibyalochan, Shukla, Aakash, Padaki, Nagaraja Rao, Valsan, Arun, Saigal, Sanjeev, Narayanaswamy, K, Mehta, Rajiv, Asati, Pankaj, Dadhich, Sunil, Mohan, Prasad V G, Rastogi, Mukul, Koshy, Abraham, Bhattacharya, Mallika, Gupta, Rohit, Roy, Akash, Maiwall, Rakhi, and Arun, J Sanyal

Published
2024
Full Text
View/download PDF

17. THU-078 Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort

Author

Choudhury, Ashok Kumar, Arora, Vinod, Rela, Mohd., Jothimani, Dinesh, Al-Mahtab, Mamun, Devarbhavi, Harshad, Eapen, CE, Goel, Ashish, Yaghi, Cesar, Ning, Qin, Chen, Tao, Duan, Zhongping, Hamid, Saeed Sadiq, Jafri, Wasim, Shukla, Akash, Tan, Soek-Siam, Kim, Dong Joon, Saraya, Anoop, Hu, Jinhua, Sood, Ajit, Goyal, Omesh, Sahoo, Manoj, Lee, Guan-Huei, Treeprasertsuk, Sombat, Thanapirom, Kessarin, Mandot, Ameet, Shah, Samir, Lesmana, Laurentius A., Ghazinyan, Hasmik, V G, Mohan Prasad, Dokmeci, A. Kadir, Sollano, Jose, Abbas, Zaigham, Shrestha, Ananta, Lau, George, Payawal, Diana, Shiha, Gamal, Duseja, Ajay Kumar, Taneja, Sunil, Padaki, Nagaraja Rao, Kulkarni, Anand, Karim, Md. Fazal, Dhiman, Radha Krishan, Mishra, Ajay, Alam, Shahinul, Yokosuka, Osamu, Chowdhury, Dr. Debashis, Kedarisetty, Chandan, Saigal, Dr Sanjiv, Arora, Anil, Kumar, Ashish, Yattoo, Ghulam Nabi, Koshy, Abraham, Kumar, Ajay, Elbasiony, Mohammed, Rathi, Pravin, Maharshi, Sudhir, Dayal, V.M., Jha, Ashish Kumar, Kalista, Kemal Fariz, Gani, Rino, Yuen, Man-Fung, Singh, Virendra, Singh, Ayaskant, Violeta, Sargsyan, Huang, Chien-Hao, Mukewar, Saurabh, Xin, Shaojie, Bhavani, Ruveena, Panackel, Charles, Dadhich, Sunil, Sachdeva, Sanjeev, Behera, Sanatan, Maji, Prabir, Kamani, Lubna, Saithanyamurthi, Hemamala Venugopal, Varghese, Dr. Joy, Parikh, Pathik, Javed, P, Saraf, Neeraj, Choudhary, Narendra S., Roy, Akash, Goenka, Mahesh, Kalal, Chetan, Devadas, Krishnadas, Adali, Gupse, Silva H, Janaka De, Omata, Masao, Sharma, Manoj, and Sarin, Shiv Kumar

Published
2024
Full Text
View/download PDF

18. THU-052 Therapeutic plasma-exchange improves short-term survival in patients with ACLF admitted to intensive care unit with organ failures-a multinational AARC data analysis

Author

Maiwall, Rakhi, Rao Pasupuleti, Samba Siva, Choudhury, Ashok Kumar, Arora, Vinod, Rela, Mohd., Jothimani, Dinesh, Al-Mahtab, Mamun, Devarbhavi, Harshad, Eapen, CE, Goel, Ashish, Yaghi, Cesar, Ning, Qin, Chen, Tao, Jia, Jidong, Duan, Zhongping, Hamid, Saeed Sadiq, Subhan, Amna, Jafri, Wasim, Shukla, Akash, Tan, Soek-Siam, Kim, Dong Joon, Saraya, Anoop, Hu, Jinhua, Sood, Ajit, Goyal, Omesh, Midha, Vandana, Sahoo, Manoj, Lee, Guan-Huei, Treeprasertsuk, Sombat, Thanapirom, Kessarin, Mandot, Ameet, Shah, Samir, Lesmana, Laurentius A., Ghazinyan, Hasmik, V G, Mohan Prasad, Dokmeci, A. Kadir, Sollano, Jose, Abbas, Zaigham, Shrestha, Ananta, Lau, George, Payawal, Diana, Shiha, Gamal, Duseja, Ajay Kumar, Taneja, Sunil, Verma, Nipun, Padaki, Nagaraja Rao, Kulkarni, Anand, Sharma, Mithun, Karim, Md. Fazal, Dhiman, Radha Krishan, Mishra, Ajay, Alam, Shahinul, Yokosuka, Osamu, Chowdhury, Debashis, Kedarisetty, Chandan, Saigal, Sanjiv, Arora, Anil, Kumar, Ashish, Koshy, Abraham, Kumar, Ajay, Elbasiony, Mohammed, Rathi, Pravin, Maharshi, Sudhir, Dayal, V.M., Jha, Ashish Kumar, Kalista, Kemal Fariz, Gani, Rino, Yuen, Man-Fung, Singh, Virendra, Singh, Ayaskant, Violeta, Sargsyan, Huang, Chien-Hao, Mukewar, Saurabh, Xin, Shaojie, Bhavani, Ruveena, Panackel, Charles, Dadhich, Sunil, Sachdeva, Sanjeev, Behera, Sanatan, Maji, Prabir, Kamani, Lubna, Saithanyamurthi, Hemamala Venugopal, Varghese, Dr. Joy, Parikh, Pathik, Javed, P, Saraf, Neeraj, Choudhary, Narendra S., Roy, Akash, Goenka, Mahesh, Kalal, Chetan, Devadas, Krishnadas, De Silva H, Janaka, and Sarin, Shiv Kumar

Published
2024
Full Text
View/download PDF

24. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation.

Author

Choudhary, Narendra S., Dhampalwar, Swapnil, Saraf, Neeraj, and Soin, Arvinder S.

Subjects
*COVID-19, *LIVER transplantation, *TREATMENT effectiveness, *CIRRHOSIS of the liver, *LIVER diseases
Abstract

Coronavirus disease 2019 (COVID-19) is associated with a significant morbidity and mortality in patients with cirrhosis. There is a significantly higher morbidity and mortality due to COVID-19 in patients with decompensated cirrhosis as compared to compensated cirrhosis, and in patients with cirrhosis as compared to noncirrhotic chronic liver disease. The fear of COVID-19 before or after liver transplantation has lead to a significant reduction in liver transplantation numbers, and patients with decompensated cirrhosis remain at risk of wait list mortality. The studies in liver transplantation recipients show that risk of mortality due to COVID-19 is generally driven by higher age and comorbidities. The current review discusses available literature regarding outcomes of COVID-19 in patients with cirrhosis and outcomes in liver transplant recipients. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

26. Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors.

Author

Choudhary, Narendra S., Saraf, Neeraj, Saigal, Sanjiv, Duseja, Ajay, Gautam, Dheeraj, Rastogi, Amit, Bhangui, Prashant, Thiagrajan, Srinivasan, and Soin, Arvinder S.

Subjects
*FATTY liver, *LIVER biopsy, *HISTOPATHOLOGY, *ALANINE aminotransferase, *ASPARTATE aminotransferase, *BODY mass index
Abstract

Generally diagnosis of non-alcoholic fatty disease is made on imaging, however, mild steatosis is difficult to diagnose on imaging. Liver biopsy is the procedure of choice but is not carried out as it is an invasive procedure. We describe our experience of 157 liver biopsies in living liver donors with normal body mass index (BMI) <23 kg/M2 (lean). The study was conducted at a tertiary care center in north India. Data of lean living donors who underwent a liver biopsy before donation were analyzed. Data are presented as percentage, mean, or median (25–75 interquartile range). Of 718 donors who had a liver biopsy before donation, 157 (21.8%) donors were lean (BMI < 23 kg/M2). Seventy-eight percent of lean donors had no or only one metabolic risk factor. Fifty-three (33.7%) of lean donors had nonalcoholic fatty liver (NAFL) in liver biopsy. When donors with NAFL were compared to donors with normal histology, donors with NAFL had significantly higher aspartate transaminase (26.6 ± 7.5 versus 23.7 ± 5.4, p = 0.007), alanine transaminase (33.4 ± 11.7 versus 27.8 ± 10.7, p = 0.003), and gamma glutamyl transpeptidase [25 (16–40.5) versus 18 (14–23), p = 0.003]. Only triglycerides (TGs) were statistically different among metabolic factors in lean NAFL and normal histology groups, 97 (70–161) versus 86 (62.5–114.7), p = 0.043. A total of 30% donors in the lean NAFL group had TGs >150 mg/dl as compared with 12.5% in the normal histology group, p = 0.009. Other metabolic risk factors were not statistically different. One third of lean donors had NAFL. Among all metabolic risk factors, only higher TGs levels showed a significant association with NAFL. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

27. Extrahepatic Malignancies and Liver Transplantation: Current Status.

Author

Choudhary, Narendra S., Saigal, Sanjiv, Saraf, Neeraj, and Soin, Arvinder S.

Subjects
*SKIN cancer, *LIVER transplantation, *LYMPHOPROLIFERATIVE disorders, *ETIOLOGY of diseases, *TOBACCO, *EARLY diagnosis
Abstract

Recipients of liver transplantation (LT) remain at higher risk (adjusted for other risk factors) of de novo malignancies (DNMs). The higher risk can be attributed to the effect of immunosuppression and patient-related risk factors (age, tobacco, alcohol, etiology of liver disease). DNMs are an important cause of late mortality in liver transplant recipients. The pattern (type) of posttransplant malignancies reflects pattern in local population. The common types include skin cancers, solid organ malignancies, and post-transplant lymphoproliferative disorders. Counseling of patients about risk factors and surveillance protocols may help in the prevention and diagnosis at early stage. We also discuss the results of LT in patients with a history of extrahepatic malignancy in the pretransplant period. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

28. Restructuring Living-Donor Liver Transplantation at a High-Volume Center During the COVID-19 Pandemic.

Author

Soin, Arvinder S., Choudhary, Narendra S., Yadav, Sanjay K., Saigal, Sanjiv, Saraf, Neeraj, Rastogi, Amit, Bhangui, Prashant, Srinivasan, Thiagarajan, Mohan, Neelam, Saha, Sujeet K., Gupta, Ankur, Chaudhary, Rohan J., Yadav, Kamal, Dhampalwar, Swapnil, Govil, Deepak, Gupta, Nikunj, and Vohra, Vijay

Subjects
*COVID-19 pandemic, *MEDICAL personnel, *LIVER transplantation, *COVID-19, *ADULTS
Abstract

Coronavirus disease 2019 (COVID-19) pandemic has led to deferral of elective transplants and proactive pretransplant testing of the donor/recipient. The impact of these on living-donor liver transplantation (LDLT) activity and outcome is not known. We performed LDLT only for sick patients or patients with advanced hepatocellular carcinoma in this period, with special COVID protocols. Patients undergoing LDLT counseling, evaluation, and transplant in the period March to June 2020 (group A) under COVID-19 restrictions and special protocols were included. LDLT activity and outcomes among these patients were compared with those in the same period in 2019 (group B). In the period March 15–June 10, we performed 39 and 23 (59%) LDLTs in 2019 and 2020, respectively. The adult patients with cirrhosis in group A (n = 20) had a significantly higher MELD score, 19.8 ± 7.0 versus 16.1 ± 5.6 in group B (n = 36), p = 0.034. Early recipient mortality was similar in 2019 (2/39) and 2020 (2/23). One of 23 post-transplant recipients, 3/71 recipients and donors during evaluation, and 8/125 healthcare workers (HCWs) developed COVID-19, all of whom recovered uneventfully. LDLT activity substantially reduced during the COVID era. The incidence and outcome of COVID-19 among the waiting or transplanted patients and HCWs were similar to those of the general population. The outcome after LDLT in the COVID era was similar to that in non-COVID times. These data suggest that LDLT may be extended to more stable patients with strict protocols. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results